探索免疫球蛋白A血管炎患者胃肠道参与的预测因素
Betül Öksel1, Nihal Şahin1, Hafize Emine Sönmez1
1Department of Pediatrics, Department of Pediatric Rheumatology, Faculty of Medicine, Kocaeli University, Kocaeli, Türkiye.
The Turkish journal of pediatrics
|November 25, 2024
概括
胃肠道 (GI) 参与免疫球蛋白A血管炎 (IgAV) 是常见的,并与炎症标志物升高有关. 系统性免疫炎症指数 (SII) 和系统性炎症反应指数 (SIRI) 可能有助于识别患有胃肠道并发症的患者.
科学领域:
- 儿科风湿病学 儿科风湿病学
- 儿科胃肠病学 儿科胃肠病学
- 系统性血管炎是什么?
背景情况:
- 免疫球蛋白A血管炎 (IgAV) 是儿童最常见的全身血管炎.
- 胃肠道 (GI) 症状发生在约50%的IgAV病例中.
- 了解胃肠道干预对于管理潜在并发症至关重要.
研究的目的:
- 分析IGAV患者的临床和实验室检测结果.
- 在IgAV中识别胃肠道并发症的潜在生物标志物.
- 评估系统性炎症指数在检测胃肠道干预方面的有用性.
主要方法:
- 对210名IgAV患者的临床和实验室数据的回顾性分析.
- 患者组之间的消化道干扰状况的比较.
- 统计分析以确定各种实验室参数和炎症指数的意义.
主要成果:
- 在210名患者中,有101名患者表现出胃肠道干扰,腹痛是最常见的症状.
- 升高的白细胞,中性细胞,单细胞和血小板数量,C反应蛋白,NLR,PLR,MLR,SII和SIRI与GI参与有显著的关联 (p<0.001).
- 对于SII,SIRI,NLR和MLR的确定的切线值表明中度灵敏度和高特异性用于识别GI参与.
结论:
- 胃肠道参与IgAV,虽然通常是自我限制的,但可能导致严重的后果.
- 系统性炎症指数,特别是SII和SIRI,显示出有前途的指标,用于识别IGAV患者的GI参与.
- 进一步的研究可能会完善这些指数用于早期检测和管理的使用.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
138
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
138
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
317
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
317
Chronic Bowel Disorders: Introduction
388
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
388
Inflammatory Bowel Disease IV: Pharmacological Management
113
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
113
Inflammatory Bowel Disease II: Crohn's Disease
185
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
185
Transcytosis of IgG
2.7K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.7K


